Vertex Pharmaceuticals (VRTX) Enterprise Value (2009 - 2026)
Vertex Pharmaceuticals' quarterly Enterprise Value came in at -$7.2 billion in Q1 2026, down 16.86% year-on-year from -$8.7 billion in Q1 2025, and down 9.66% quarter-over-quarter from -$6.6 billion in Q4 2025.
Vertex Pharmaceuticals has reported Enterprise Value for 18 years, with the latest figure at -$7.2 billion in Q1 2026.
- For the quarter ending Q1 2026, Enterprise Value fell 16.86% year-over-year to -$7.2 billion; the trailing twelve-month figure through Mar 2026 stood at -$7.2 billion (down 16.86% YoY), and the FY2025 full-year result was -$6.6 billion, down 8.05% from the prior year.
- Enterprise Value for Q1 2026 stood at -$7.2 billion, down from -$6.6 billion in the prior quarter.
- The five-year high for Enterprise Value was -$5.8 billion in Q2 2024, with the low at -$11.9 billion in Q3 2023.
- Average Enterprise Value over 5 years is -$8.5 billion, with a median of -$8.2 billion recorded in 2022.
- Year-over-year, Enterprise Value plunged 43.24% in 2022 and jumped 48.42% in 2024.
- Tracing VRTX's Enterprise Value over 5 years: stood at -$10.8 billion in 2022, then retreated by 4.08% to -$11.2 billion in 2023, then jumped by 45.48% to -$6.1 billion in 2024, then decreased by 8.05% to -$6.6 billion in 2025, then declined by 9.66% to -$7.2 billion in 2026.
- The last three Enterprise Value figures came in at -$7.2 billion (Q1 2026), -$6.6 billion (Q4 2025), and -$6.3 billion (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -2.32 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | -32.30 Mn |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -286.70 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | -61.46 Mn |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -2.77 Mn |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | -7.25 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | -18.44 Mn |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -8.75 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | -3.01 Bn |
| 10 | Revolution Medicines | 32.39 Bn | 32.39 Bn | - | -1.91 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -7.25 Bn |
| Dec 31, 2025 | -6.61 Bn |
| Sep 30, 2025 | -6.29 Bn |
| Jun 30, 2025 | -6.38 Bn |
| Mar 31, 2025 | -6.20 Bn |
| Dec 31, 2024 | -6.12 Bn |
| Sep 30, 2024 | -6.52 Bn |
| Jun 30, 2024 | -5.80 Bn |
| Mar 31, 2024 | -10.17 Bn |
| Dec 31, 2023 | -11.22 Bn |
| Sep 30, 2023 | -11.93 Bn |
| Jun 30, 2023 | -11.24 Bn |
| Mar 31, 2023 | -10.41 Bn |
| Dec 31, 2022 | -10.78 Bn |
| Sep 30, 2022 | -9.77 Bn |
| Jun 30, 2022 | -9.25 Bn |
| Mar 31, 2022 | -8.24 Bn |
| Dec 31, 2021 | -7.52 Bn |
| Sep 30, 2021 | -6.96 Bn |
| Jun 30, 2021 | -6.71 Bn |
| Mar 31, 2021 | -6.92 Bn |
| Dec 31, 2020 | -6.66 Bn |
| Sep 30, 2020 | -6.15 Bn |
| Jun 30, 2020 | -5.45 Bn |
| Mar 31, 2020 | -4.19 Bn |
| Dec 31, 2019 | -3.81 Bn |
| Sep 30, 2019 | -4.00 Bn |
| Jun 30, 2019 | -3.95 Bn |
| Mar 31, 2019 | -3.48 Bn |
| Dec 31, 2018 | -3.17 Bn |
| Sep 30, 2018 | -3.03 Bn |
| Jun 30, 2018 | -2.74 Bn |
| Mar 31, 2018 | -2.45 Bn |
| Dec 31, 2017 | -2.07 Bn |
| Sep 30, 2017 | -1.80 Bn |
| Jun 30, 2017 | -1.47 Bn |
| Mar 31, 2017 | -266.88 Mn |
| Dec 31, 2016 | -1.25 Bn |
| Sep 30, 2016 | -941.65 Mn |
| Jun 30, 2016 | -883.95 Mn |
| Mar 31, 2016 | -866.50 Mn |
| Dec 31, 2015 | -888.80 Mn |
| Sep 30, 2015 | -851.25 Mn |
| Jun 30, 2015 | -863.20 Mn |
| Mar 31, 2015 | -1.16 Bn |
| Dec 31, 2014 | -1.37 Bn |
| Sep 30, 2014 | -1.48 Bn |
| Jun 30, 2014 | -1.22 Bn |
| Mar 31, 2014 | -1.32 Bn |
| Dec 31, 2013 | -1.47 Bn |
| Sep 30, 2013 | -1.24 Bn |
| Jun 30, 2013 | -1.39 Bn |
| Mar 31, 2013 | -1.05 Bn |
| Dec 31, 2012 | -1.12 Bn |
| Sep 30, 2012 | -1.26 Bn |
| Jun 30, 2012 | -1.19 Bn |
| Mar 31, 2012 | -1.13 Bn |
| Dec 31, 2011 | -827.29 Mn |
| Sep 30, 2011 | -544.30 Mn |
| Jun 13, 2011 | 31.72 Mn |
| Mar 31, 2011 | -823.45 Mn |
| Dec 31, 2010 | -1.03 Bn |
| Sep 30, 2010 | -1.20 Bn |
| Jun 30, 2010 | -979.15 Mn |
| Mar 31, 2010 | -1.09 Bn |
| Dec 31, 2009 | -1.28 Bn |
| Sep 30, 2009 | -559.13 Mn |
| Jun 30, 2009 | -408.95 Mn |
| Mar 31, 2009 | -602.20 Mn |